Evidence map›Paper›PMID 28397869›Full record

ArticleScientific reports2017

Adsorption energy as a metric for wettability at the nanoscale.

Ronaldo Giro, Peter W Bryant, Michael Engel, Rodrigo F Neumann, Mathias B Steiner

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ronaldo GiroIBM Research, Av. Pasteur 138/146, CEP 22290-240, Rio de Janeiro, RJ, Brazil.
Peter W BryantIBM Research, Av. Pasteur 138/146, CEP 22290-240, Rio de Janeiro, RJ, Brazil.
Michael EngelIBM Research, Av. Pasteur 138/146, CEP 22290-240, Rio de Janeiro, RJ, Brazil.
Rodrigo F NeumannIBM Research, Av. Pasteur 138/146, CEP 22290-240, Rio de Janeiro, RJ, Brazil.
Mathias B SteinerIBM Research, Av. Pasteur 138/146, CEP 22290-240, Rio de Janeiro, RJ, Brazil.
IBM Research - Brazil · BRIBM (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wettability is the affinity of a liquid for a solid surface. For energetic reasons, macroscopic drops of liquid form nearly spherical caps. The degree of wettability is then captured by the contact angle where the liquid-vapor interface meets the solid-liquid interface. As droplet volumes shrink to the scale of attoliters, however, surface interactions become significant, and droplets assume distorted shapes. In this regime, the contact angle becomes ambiguous, and a scalable metric for quantifying wettability is needed, especially given the emergence of technologies exploiting liquid-solid interactions at the nanoscale. Here we combine nanoscale experiments with molecular-level simulation to study the breakdown of spherical droplet shapes at small length scales. We demonstrate how measured droplet topographies increasingly reveal non-spherical features as volumes shrink. Ultimately, the nanoscale droplets flatten out to form layer-like molecular assemblies at the solid surface. For the lack of an identifiable contact angle at small scales, we introduce a droplet's adsorption energy density as a new metric for a liquid's affinity for a surface. We discover that extrapolating the macroscopic idealization of a drop to the nanoscale, though it does not geometrically resemble a realistic droplet, can nonetheless recover its adsorption energy if line tension is included.

Identifiers

PMID28397869
PMCPMC5387734
OpenAlexW2516555888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.